 |
|
|
History
Amygdalin was first isolated in 1830 by 2 French chemists. Reviewed in
[1,2] It was used as an anticancer agent in Russia as early as 1845, with
positive results reported for the first patient treated. Reviewed in [3,4] Its
first recorded use in the United States as a treatment for cancer occurred in
the early 1920s. Reviewed in [5] At that time, amygdalin was taken in pill
form; however, the formulation was judged too toxic, and the work was
abandoned. In the 1950s, a purportedly nontoxic intravenous form of amygdalin
was patented as Laetrile. Reviewed in [1,6,7]
Laetrile has been tested on cultured animal cells (cells grown
in specialized containers in the laboratory), in whole animals, in xenograft models (tumor cells from one
species transplanted onto another species), and in humans to determine whether
it has specific anticancer properties (an ability to kill cancer cells more
readily than normal cells). As noted previously (General Information 1), cyanide is believed to be the main cancer-killing ingredient in
laetrile.[8,9] When amygdalin interacts with the enzyme beta-glucosidase
or undergoes hydrolysis (breakdown in
a reaction with water) in the absence of enzymes, hydrogen cyanide, benzaldehyde, and glucose (sugar) are
produced. Reviewed in [1,7,8,10,11] Cyanide can also be produced from
prunasin, which is a less-than-complete breakdown product of
amygdalin. Reviewed in [1,8]
Four different theories have been advanced to explain the anticancer
activity of laetrile. The first of these incorporates elements of the
trophoblastic theory of cancer, a theory that is not widely accepted as an
explanation for cancer formation. According to the trophoblastic theory, all
cancers arise from primordial germ cells (cells that, under normal
circumstances, would give rise to eggs or sperm), some of which become
dispersed throughout the body during embryonic development and, therefore, are not confined to the testes or ovaries. The trophoblastic theory also suggests that transformation of
primordial germ cells to a cancerous state is normally prevented by enzymes
from the pancreas, and that cancers can
be destroyed by pancreatic enzyme supplements and treatment with laetrile.[12] Reviewed in [13-17] The rationale
for laetrile use is the suggestion that malignant cells have higher than
normal levels of an enzyme called beta-glucuronidase (which is different from
the aforementioned enzyme beta-glucosidase) and that they are deficient in
another enzyme called rhodanese (thiosulfate sulfurtransferase). It has been
suggested further that laetrile is modified in the liver and that
beta-glucuronidase breaks down the modified compound, ultimately producing
cyanide. Rhodanese can convert cyanide into the relatively harmless compound
thiocyanate. Thus, it has been proposed that cancer cells are more
susceptible to the toxic effects of laetrile than normal cells because of an
imbalance in these 2 enzymes. Reviewed in [10,13,18-20] It is important to
note that there is no experimental evidence to support the idea that normal tissues and malignant tissues differ substantially in their concentrations of
beta-glucuronidase or rhodanese.[21,22]
The second theory states that cancer cells contain more beta-glucosidase
activity than normal cells and, as in the first theory, that they are
deficient in rhodanese. Reviewed in [1,5,13,15,18,23,24] Evidence from
laboratory studies demonstrates that this theory cannot be supported. As
noted previously, normal cells and cancer cells contain similar amounts of
rhodanese.[21] Furthermore, most types of mammalian cells contain only small
traces of beta-glucosidase,[22] and this enzyme has not been detected in tumor
samples [8,25] or in human blood.[5] Without sufficient levels of
beta-glucosidase, it is difficult for intravenously administered amygdalin to
be broken down into cyanide and other products.
The third theory states that cancer is the result of a metabolic disorder caused by a vitamin deficiency. It states further that laetrile, or “vitamin B-17,” is
the missing vitamin needed by the body to restore health. Reviewed in
[18,26-28] Experimental evidence indicates that the level of intake of
individual vitamins and/or the vitamin status of an organism can influence the development of
cancer, but there is no evidence that laetrile is needed for normal metabolism or that it can function as a
vitamin in animals or humans. Reviewed in [29,30]
The fourth theory suggests that the cyanide released by laetrile has a
toxic effect beyond its interference with oxygen utilization by cells.
According to this theory, cyanide increases the acid content of tumors and
leads to the destruction of lysosomes (compartments inside cells that contain enzymes capable of breaking down other
cellular molecules). The injured
lysosomes release their contents, thereby killing the cancer cells and
arresting tumor growth. Reviewed in [15] According to this theory, another
consequence of lysosome disruption is stimulation of the immune system.
References
-
Dorr RT, Paxinos J: The current status of laetrile. Ann Intern Med 89 (3): 389-97, 1978.
[PUBMED Abstract]
-
Viehoever A, Mack H: Bio-chemistry of amygdalin (bitter, cyanogenetic principle from bitter almonds). Am J Pharm 107(Oct): 397-450, 1935.
-
The laetrile controversy. In: Moss RW: The Cancer Industry: The Classic Expose on the Cancer Establishment. Brooklyn, NY: First Equinox Press, 1996, pp 131-52.
-
Laetrile at Sloan-Kettering: a case study. In: Moss RW: The Cancer Industry: The Classic Expose on the Cancer Establishment. Brooklyn, NY: First Equinox Press, 1996, pp 153-86.
-
Curt GA: Unsound methods of cancer treatment. Princ Pract Oncol Updates 4 (12): 1-10, 1990.
-
Fenselau C, Pallante S, Batzinger RP, et al.: Mandelonitrile beta-glucuronide: synthesis and characterization. Science 198 (4317): 625-7, 1977.
[PUBMED Abstract]
-
Chandler RF, Anderson LA, Phillipson JD: Laetrile in perspective. Can Pharm J 117 (11): 517-20, 1984.
-
Newmark J, Brady RO, Grimley PM, et al.: Amygdalin (Laetrile) and prunasin beta-glucosidases: distribution in germ-free rat and in human tumor tissue. Proc Natl Acad Sci U S A 78 (10): 6513-6, 1981.
[PUBMED Abstract]
-
Rauws AG, Olling M, Timmerman A: The pharmacokinetics of prunasin, a metabolite of amygdalin. J Toxicol Clin Toxicol 19 (8): 851-6, 1982.
[PUBMED Abstract]
-
Ross WE: Unconventional cancer therapy. Compr Ther 11 (9): 37-43, 1985.
[PUBMED Abstract]
-
Ames MM, Moyer TP, Kovach JS, et al.: Pharmacology of amygdalin (laetrile) in cancer patients. Cancer Chemother Pharmacol 6 (1): 51-7, 1981.
[PUBMED Abstract]
-
Krebs ET Jr, Krebs ET Sr, Beard HH: The unitarian or trophoblastic thesis of cancer. Med Rec 163 (7): 149-74, 1950.
-
Ellison NM: Unproven methods of cancer therapy. Drug Ther (NY) 10(July): 73-82, 1980.
-
Navarro MD: The Philippine experience in the early detection and chemotherapy of cancer. St Tomas J Med 25 (3): 125-33, 1970.
-
Greenberg DM: The case against laetrile: the fraudulent cancer remedy. Cancer 45 (4): 799-807, 1980.
[PUBMED Abstract]
-
Levi L, French WN, Bickis IJ, et al.: Laetrile: a study of its physicochemical and biochemical properties. Can Med Assoc J 92: 1057-61, 1965.
-
Cancer Commission of the California Medical Association.: The treatment of cancer with "laetriles". Calif Med 78 (4): 320-26, 1953.
-
Unproven methods of cancer management. Laetrile. CA Cancer J Clin 22 (4): 245-50, 1972 Jul-Aug.
[PUBMED Abstract]
-
Navarro MD: Five years experience with laetrile therapy in advanced cancer. Acta Unio Int Contr Cancrum 15(suppl 1): 209-21, 1959.
-
Morrone JA: Chemotherapy of inoperable cancer: preliminary report of 10 cases treated with laetrile. Exp Med Surg 20: 299-308, 1962.
-
Gal EM, Fung FH, Greenberg DM: Studies on the biological action of malononitriles, II: distribution of rhodanese (transulfurase) in the tissues of normal and tumor-bearing animals and the effect of malononitriles thereon. Cancer Res 12: 574-79, 1952.
-
Conchie J, Findlay J, Levvy GA: Mammalian glycosidases: distribution in the body. Biochem J 71: 318-25, 1959.
-
Herbert V: Laetrile: the cult of cyanide. Promoting poison for profit. Am J Clin Nutr 32 (5): 1121-58, 1979.
[PUBMED Abstract]
-
Scott PJ: Laetrile and cancer quackery problems. Cancer Forum 5 (2): 93-97, 1981.
-
Biaglow JE, Durand RE: The enhanced radiation response of an in vitro tumour model by cyanide released from hydrolysed amygdalin. Int J Radiat Biol Relat Stud Phys Chem Med 33 (4): 397-401, 1978.
[PUBMED Abstract]
-
Lerner IJ: Laetrile: a lesson in cancer quackery. CA Cancer J Clin 31 (2): 91-5, 1981 Mar-Apr.
[PUBMED Abstract]
-
Lerner IJ: The whys of cancer quackery. Cancer 53 (3 Suppl): 815-9, 1984.
[PUBMED Abstract]
-
Shils ME, Hermann MG: Unproved dietary claims in the treatment of patients with cancer. Bull N Y Acad Med 58 (3): 323-40, 1982.
[PUBMED Abstract]
-
Young VR, Newberne PM: Vitamins and cancer prevention: issues and dilemmas. Cancer 47 (5 Suppl): 1226-40, 1981.
[PUBMED Abstract]
-
Jukes TH: Laetrile struggles. Nature 263 (5578): 543, 1976.
|
Glossary Terms
amygdalin (uh-MIG-duh-lin)
A substance found in the pits of many fruits such as apricots and papayas, and in other foods. It has been tried in some countries as a treatment for cancer, but it has not been shown to work in clinical studies. Amygdalin is not approved for use in the United States. Also called laetrile.
benzaldehyde
A colorless oily liquid used as a flavoring agent and to make dyes, perfumes, and pharmaceuticals. Benzaldehyde is chemically related to benzene.
cancer (KAN-ser)
A term for
diseases in which abnormal cells divide without control and
can invade nearby tissues. Cancer cells can also spread to
other parts of the body through the blood and lymph
systems. There are several main types of cancer. Carcinoma
is a cancer that begins in the skin or in tissues that line
or cover internal organs. Sarcoma is a cancer that begins in
bone, cartilage, fat, muscle, blood vessels, or other
connective or supportive tissue. Leukemia is a cancer that
starts in blood-forming tissue such as the bone marrow, and
causes large numbers of abnormal blood cells to be produced
and enter the blood. Lymphoma and multiple myeloma are
cancers that begin in the cells of the immune system.
Central nervous system cancers are cancers that begin in
the tissues of the brain and spinal cord. Also called malignancy.
cell (sel)
The individual unit that makes up the tissues of the body. All living things are made up of one or more cells.
cultured cell
A human, plant, or animal cell that has been adapted to grow in the laboratory. Cultured cells may be used to diagnose infections, to test new drugs, and in research.
deficiency (dih-FIH-shun-see)
In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.
embryonic
Having to do with an embryo, which is an early stage in the development of a plant or animal.
enzyme (EN-zime)
A protein that speeds up chemical reactions in the body.
germ cell (jerm sel)
A reproductive cell of the body. Germ cells are egg cells in females and sperm cells in males.
glucose
A type of sugar; the chief source of energy for living organisms.
hydrolysis
A chemical reaction that uses water to break down a compound.
immune system (ih-MYOON SIS-tem)
The complex group of organs and cells that defends the body against infections and other diseases.
intravenous (IN-truh-VEE-nus)
Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein. Also called IV.
laetrile (LAY-eh-tril)
A substance found in the pits of many fruits such as apricots and papayas, and in other foods. It has been tried in some countries as a treatment for cancer, but it has not been shown to work in clinical studies. Laetrile is not approved for use in the United States. Also called amygdalin.
liver
A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.
lysosome
A sac-like compartment inside a cell that has enzymes that can break down cellular components that need to be destroyed.
malignant (muh-LIG-nunt)
Cancerous. Malignant tumors can invade and destroy nearby tissue and spread to other parts of the body.
metabolic disorder (MEH-tuh-BAH-lik dis-OR-der)
A condition in which normal metabolic processes are disrupted, usually because of a missing enzyme.
metabolism (meh-TA-boh-lih-zum)
The total of all chemical changes that take place in a cell or an organism. These changes make energy and the materials needed for growth, reproduction, and maintaining health. They also help get rid of toxic substances.
molecule
The smallest particle of a substance that has all of the physical and chemical properties of that substance. Molecules are made up of one or more atoms. If they contain more than one atom, the atoms can be the same (an oxygen molecule has two oxygen atoms) or different (a water molecule has two hydrogen atoms and one oxygen atom). Biological molecules, such as proteins and DNA, can be made up of many thousands of atoms.
nontoxic (non-TOK-sik)
Not harmful or destructive.
organism
A living thing, such as an animal, a plant, a bacterium, or a fungus.
ovary (OH-vuh-ree)
One of a pair of female reproductive glands in which the ova, or eggs, are formed. The ovaries are located in the pelvis, one on each side of the uterus.
pancreas (PAN-kree-us)
A glandular organ located in the abdomen. It makes pancreatic juices, which contain enzymes that aid in digestion, and it produces several hormones, including insulin. The pancreas is surrounded by the stomach, intestines, and other organs.
pancreatic
Having to do with the pancreas.
sperm (spurm)
The male reproductive cell, formed in the testicle. A sperm unites with an egg to form an embryo.
supplementation
Adding nutrients to the diet.
testis (TES-tis)
One of two egg-shaped glands inside the scrotum that produce sperm and male hormones. Also called testicle.
tissue (TISH-oo)
A group or layer of cells that work together to perform a specific function.
toxic (TOK-sik)
Having to do with poison or something harmful to the body. Toxic substances usually cause unwanted side effects.
transplantation (tranz-plan-TAY-shun)
A surgical procedure in which tissue or an organ is transferred from one area of a person’s body to another area, or from one person (the donor) to another person (the recipient).
tumor (TOO-mer)
An abnormal mass of tissue that results when cells divide more than they should or do not die when they should. Tumors may be benign (not cancer), or malignant (cancer). Also called neoplasm.
vitamin (VY-tuh-min)
A nutrient that the body needs in small amounts to function and stay healthy. Sources of vitamins are plant and animal food products and dietary supplements. Some vitamins are made in the human body from food products. Vitamins are either fat-soluble (can dissolve in fats and oils) or water-soluble (can dissolve in water). Excess fat-soluble vitamins are stored in the body’s fatty tissue, but excess water-soluble vitamins are removed in the urine. Examples are vitamin A, vitamin C, and vitamin E.
xenograft (ZEE-noh-graft)
The transplant of an organ, tissue, or cells to an individual of another species.
|
Table of Links
| 1 | http://www.cancer.gov/cancertopics/pdq/cam/laetrile/HealthProfessional/5.cdr#Se ction_5 |
|
 |